Trial Profile
A Pilot Trial Examining the Safety and Efficacy of Frovatriptan as a Preemptive Treatment for Fasting-Induced Migraine Headache.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Frovatriptan (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 23 Mar 2011 Primary endpoint 'Additional-treatment-required---rescue-medication' has not been met
- 17 Nov 2010 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 17 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.